Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection

Emily Mantlo; Natalya Bukreyeva; Junki Maruyama; Slobodan Paessler; Cheng Huang

doi:10.1101/2020.04.02.022764

Article Information

doi

https://doi.org/10.1101/2020.04.02.022764

History

April 5, 2020.

Article Versions

Version 1 (April 5, 2020 - 16:03).
You are viewing Version 2, the most recent version of this article.

The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

Emily Mantlo1,
Natalya Bukreyeva1,
Junki Maruyama1,
Slobodan Paessler1,2 and
Cheng Huang1,2,*

¹Department of Pathology and University of Texas Medical Branch, Galveston, Texas, United States of America
²Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America

↵*Correspondent author: Cheng Huang, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX 77555-0609, USA, Email: chhuang{at}utmb.edu